ONC - BeiGene, Ltd.
299.02
1.980 0.662%
Share volume: 337,602
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$297.04
1.98
0.01%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-27-2025 | 05-07-2025 | 08-06-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | ||||||
| Total Assets | 5.921 B | 5.842 B | 6.298 B | 7.633 B | 8.189 B | |
| Current Assets | 3.992 B | 3.896 B | 4.310 B | 5.664 B | 6.234 B | |
| Inventories | 494.986 M | 494.660 M | 502.867 M | 531.687 M | 608.227 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.627 B | 2.516 B | 2.756 B | 4.037 B | 4.548 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.578 B | 1.599 B | 1.616 B | 1.628 B | 1.642 B | |
| Other Assets | 350.894 M | 346.446 M | 372.381 M | 339.995 M | 313.306 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 5.921 B | 5.842 B | 6.298 B | 7.633 B | 8.189 B | |
| Total liabilities | 2.589 B | 2.342 B | 2.528 B | 3.503 B | 3.827 B | |
| Total current liabilities | 2.215 B | 1.984 B | 2.210 B | 2.368 B | 1.829 B | |
| Accounts Payable | 404.997 M | 364.498 M | 360.783 M | 383.676 M | 479.035 M | |
| Other liabilities | 165.298 M | 155.025 M | 127.898 M | 115.443 M | 983.427 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 166.484 M | 160.157 M | 146.091 M | 972.326 M | 961.913 M | |
| Other liabilities | 165.298 M | 155.025 M | 127.898 M | 115.443 M | 983.427 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.332 B | 3.500 B | 3.770 B | 4.129 B | 4.361 B | |
| Common stock | 12.088 B | 12.247 B | 12.395 B | 12.617 B | 12.759 B | |
| Retained earnings | -8.607 B | -8.606 B | -8.511 B | -8.386 B | -8.320 B |